SPP-037

CAT: 0804-HY-172888-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-172888-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SPP-037 is an orally active and selective inhibitor of ST6GAL1 (IC50: 3.59 μM) . SPP-037 exhibits anti-MDA-MB-231 cell migration activity by inhibiting integrin α2,6-sialylation and integrin-FAK-paxillin pathway. SPP-037 has anti-tumor activity in MDA-MB-231 xenograft mouse model. SPP-037 can be used in breast cancer research[1].
UNSPSC
12352211
Target
Endogenous Metabolite; FAK
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
[H][C@]12CC[C@@]3([C@H](CC[C@]3([C@@]1(CC[C@@]4(C[C@@H](CC[C@]24C)OC([C@@H](NS(=O)(C5=CC=C(C6=NON=C56)Cl)=O)CC(O)=O)=O)[H])[H])[H])[C@@H](CCCCC(O)=O)C)C
Molecular Formula
C36H50ClN3O9S
Molecular Weight
736.31
References & Citations
[1]Perez SJLP, et al. Harnessing the bishomolithocholic acid scaffold for selective sialyltransferase inhibition: A targeted approach to suppress breast cancer metastasis. Eur J Med Chem. 2025 Aug 5;292:117674.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-151626MRV03-037
HY-178391SMU-037
HY-171787PPA-037
HY-113719VM4-037
HY-159100-01PVP-037
HY-128926-01SPP
HY-159102-01PVP-037.2
HY-171787A-01PPA-037 (TFA)
HY-126491-01SPP-DM1
HY-129367NO2-SPP

Alternative Products

CatalogName
MF-0115199-01SPP-037
MBS5784548VM4-037
MBS5816908MRV03-037
MBS130597-01AZ-037
MF-0148218-01PVP-037
MF-0115435-01PPA-037
MBS3842909-01SPP
abx411232Clostridium spp. (C. spp.) Antibody
MF-0122167-01PVP-037.2
453112-01L-138,037

Popular Products